Blair William & CO Ovid Therapeutics Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Blair William & CO holds 32,039 shares of OVID stock, worth $33,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,039

Previous 31,039 3.22%

Holding current value

$33,000

Previous $23,000 60.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.75 - $1.3 $750 - $1,300	1,000 Added 3.22%	32,039 $37,000
Q2 2024 Aug 12, 2024	BUY	$0.7 - $3.34 $4,970 - $23,714	7,100 Added 29.66%	31,039 $23,000
Q1 2024 May 09, 2024	BUY	$2.72 - $4.04 $6,155 - $9,142	2,263 Added 10.44%	23,939 $73,000
Q4 2023 Feb 12, 2024	SELL	$2.98 - $3.78 $1,194 - $1,515	-401 Reduced 1.82%	21,676 $69,000
Q3 2023 Nov 09, 2023	SELL	$3.23 - $3.97 $4,037 - $4,962	-1,250 Reduced 5.36%	22,077 $84,000
Q2 2023 Aug 11, 2023	SELL	$2.53 - $3.89 $2,532 - $3,893	-1,001 Reduced 4.11%	23,327 $76,000
Q4 2022 Feb 10, 2023	SELL	$1.43 - $1.89 $9,867 - $13,041	-6,900 Reduced 22.1%	24,328 $45,000
Q2 2022 Aug 10, 2022	SELL	$1.69 - $3.31 $45,861 - $89,823	-27,137 Reduced 46.5%	31,228 $67,000
Q1 2022 May 13, 2022	SELL	$2.65 - $3.49 $86,090 - $113,379	-32,487 Reduced 35.76%	58,365 $183,000
Q4 2021 Feb 14, 2022	SELL	$3.13 - $3.73 $19,236 - $22,924	-6,146 Reduced 6.34%	90,852 $292,000
Q3 2021 Nov 12, 2021	SELL	$3.31 - $4.04 $65,412 - $79,838	-19,762 Reduced 16.93%	96,998 $326,000
Q2 2021 Aug 12, 2021	SELL	$3.3 - $4.49 $131,082 - $178,351	-39,722 Reduced 25.38%	116,760 $457,000
Q1 2021 May 13, 2021	BUY	$2.42 - $4.47 $45,549 - $84,134	18,822 Added 13.67%	156,482 $629,000
Q4 2020 Feb 09, 2021	SELL	$2.28 - $6.84 $61,733 - $185,199	-27,076 Reduced 16.44%	137,660 $318,000
Q3 2020 Nov 06, 2020	BUY	$5.39 - $8.24 $469,900 - $718,363	87,180 Added 112.41%	164,736 $946,000
Q2 2020 Aug 12, 2020	BUY	$2.67 - $7.91 $33,524 - $99,317	12,556 Added 19.32%	77,556 $572,000
Q1 2020 May 11, 2020	SELL	$2.03 - $4.35 $254,263 - $544,850	-125,253 Reduced 65.83%	65,000 $194,000
Q4 2019 Feb 13, 2020	BUY	$2.08 - $5.06 $395,726 - $962,680	190,253 New	190,253 $790,000

Others Institutions Holding OVID

# of Institutions

Shares Held

39M

Call Options Held

37.4K

Put Options Held

500

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $72.5M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account